Bright Net Receivables vs Total Assets Analysis
| DRUG Stock | USD 1.10 0.04 3.77% |
Bright Minds financial indicator trend analysis is way more than just evaluating Bright Minds Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bright Minds Biosciences is a good investment. Please check the relationship between Bright Minds Net Receivables and its Total Assets accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
Net Receivables vs Total Assets
Net Receivables vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bright Minds Biosciences Net Receivables account and Total Assets. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Bright Minds' Net Receivables and Total Assets is -0.18. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Total Assets in the same time period over historical financial statements of Bright Minds Biosciences, assuming nothing else is changed. The correlation between historical values of Bright Minds' Net Receivables and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Bright Minds Biosciences are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Net Receivables i.e., Bright Minds' Net Receivables and Total Assets go up and down completely randomly.
Correlation Coefficient | -0.18 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Net Receivables
Total Assets
Total assets refers to the total amount of Bright Minds assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bright Minds Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most indicators from Bright Minds' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bright Minds Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. The current Selling General Administrative is estimated to decrease to about 1.2 M. The current Issuance Of Capital Stock is estimated to decrease to about 1 M
Bright Minds fundamental ratios Correlations
Click cells to compare fundamentals
Bright Minds Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bright Minds fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 880.2K | 20.0M | 12.1M | 6.9M | 7.9M | 8.8M | |
| Other Current Liab | 12.5K | 42K | 158.2K | 25K | 28.8K | 27.3K | |
| Total Current Liabilities | 150.9K | 638.6K | 1.5M | 280.9K | 323.0K | 567.5K | |
| Total Stockholder Equity | 729.3K | 19.4M | 10.5M | 6.6M | 7.6M | 8.2M | |
| Net Debt | (799.9K) | (19.8M) | (11.5M) | (6.7M) | (6.0M) | (6.3M) | |
| Retained Earnings | (559.1K) | (9.2M) | (24.2M) | (31.5M) | (28.4M) | (27.0M) | |
| Accounts Payable | 138.4K | 596.6K | 1.2M | 182.3K | 209.7K | 199.2K | |
| Cash | 799.9K | 19.8M | 11.6M | 6.7M | 7.8M | 8.6M | |
| Cash And Short Term Investments | 799.9K | 19.8M | 11.6M | 6.7M | 7.8M | 8.6M | |
| Liabilities And Stockholders Equity | 880.2K | 20.0M | 12.1M | 6.9M | 7.9M | 8.8M | |
| Other Stockholder Equity | 146.4K | (33.7K) | 10.5T | 831.8K | 956.6K | 908.8K | |
| Total Liab | 150.9K | 638.6K | 1.5M | 280.9K | 323.0K | 583.3K | |
| Total Current Assets | 878.2K | 20.0M | 11.9M | 6.8M | 7.8M | 8.7M | |
| Accumulated Other Comprehensive Income | 161.3K | 1.6M | 2.5M | 3.4M | 3.9M | 4.1M | |
| Common Stock | 980.7K | 27.1M | 32.2M | 33.9M | 39.0M | 20.8M |
Currently Active Assets on Macroaxis
When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Bright Stock analysis
When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Bright Minds' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.30) | Return On Assets (0.38) | Return On Equity (0.72) |
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.